Myeloproliferative neoplasm primary prevention: Difference between revisions
Shyam Patel (talk | contribs) No edit summary |
Shyam Patel (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Myeloproliferative disease}} | {{Myeloproliferative disease}} | ||
{{CMG}}{{AE}} {{MJK}} | {{CMG}}{{AE}} {{MJK}} {{shyam}} | ||
==Overview== | ==Overview== | ||
There is no established method for primary prevention of myeloproliferative neoplasm.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative</ref> | There is no established method for primary prevention of myeloproliferative neoplasm.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative</ref> |
Revision as of 23:34, 23 June 2018
Myeloproliferative Neoplasm Microchapters |
Differentiating myeloproliferative neoplasm from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Myeloproliferative neoplasm primary prevention On the Web |
American Roentgen Ray Society Images of Myeloproliferative neoplasm primary prevention |
Directions to Hospitals Treating Myeloproliferative neoplasm |
Risk calculators and risk factors for Myeloproliferative neoplasm primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Shyam Patel [3]
Overview
There is no established method for primary prevention of myeloproliferative neoplasm.[1]
Primary Prevention
There is no established method for primary prevention of myeloproliferative neoplasm.[1] Routine monitoring of the complete blood count on a yearly basis is sufficient for monitoring.
References
- ↑ 1.0 1.1 National Cancer Institute. Physician Data Query Database 2015.http://www.cancer.gov/types/myeloproliferative